Tag : meets

Latest News

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

Newsemia
Genentech, a member of the Roche Group , announced today that the randomized Phase III CLL14 study, which evaluated fixed-duration Venclexta® in combination with Gazyva®...
AI/ML

Machine Meets Biology: a Primer on Artificial Intelligence in Cardiology and Cardiac Imaging.

Newsemia
Related Articles Machine Meets Biology: a Primer on Artificial Intelligence in Cardiology and Cardiac Imaging. Curr Cardiol Rep. 2018 Oct 18;20(12):139 Authors: Dilsizian ME, Siegel...
Gastroenterology

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

Newsemia
Seattle Genetics, Inc. and Takeda Pharmaceutical Company Limited announced today that the phase 3 ECHELON-2 clinical trial met its primary endpoint. Source link...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy